Skip to content

Clinical trials

Completed Leukemia, Lymphocytic, Chronic, B-Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Completed Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20096
20101
20111
20121
20142
20163
20171
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Celgene3
AstraZeneca2
AbbVie1
BeiGene1
European Organisation for Research and Treatment of Cancer - EORTC1
European Society for Blood and Marrow Transplantation1
Genentech, Inc.1
German CLL Study Group1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell21
Lymphoma, Non-Hodgkin5
Recurrence5
Hodgkin Disease3
Lymphoma, Mantle-Cell3
Neoplasms3
Leukemia, B-Cell2
Leukemia, Myeloid, Acute2
Leukemia, Myelomonocytic, Chronic2
Lymphoma, B-Cell2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.